Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1988 1
1989 1
1990 1
1991 5
1992 2
1994 4
1995 1
1996 4
1997 8
1998 5
1999 5
2000 6
2001 4
2002 1
2003 3
2004 3
2005 6
2006 5
2007 4
2008 4
2009 11
2010 13
2011 10
2012 21
2013 24
2014 33
2015 39
2016 33
2017 35
2018 38
2019 42
2020 31
2021 51
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

410 results
Results by year
Filters applied: . Clear all
Page 1
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease.
Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, Agusti AA, Vogelmeier CF. Halpin DMG, et al. Among authors: agusti aa. Am J Respir Crit Care Med. 2021 Jan 1;203(1):24-36. doi: 10.1164/rccm.202009-3533SO. Am J Respir Crit Care Med. 2021. PMID: 33146552 Free PMC article. Review.
Patients who developed moderate-to-severe COVID-19, including hospitalization and pneumonia, should be treated with evolving pharmacotherapeutic approaches as appropriate, including remdesivir, dexamethasone, and anticoagulation. ...
Patients who developed moderate-to-severe COVID-19, including hospitalization and pneumonia, should be treated with evolving pharmaco …
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019.
Singh D, Agusti A, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Criner GJ, Frith P, Halpin DMG, Han M, López Varela MV, Martinez F, Montes de Oca M, Papi A, Pavord ID, Roche N, Sin DD, Stockley R, Vestbo J, Wedzicha JA, Vogelmeier C. Singh D, et al. Among authors: agusti a. Eur Respir J. 2019 May 18;53(5):1900164. doi: 10.1183/13993003.00164-2019. Print 2019 May. Eur Respir J. 2019. PMID: 30846476 Free article. Review.
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic and biological information in order to optimise the therapeutic benefit relative to the possibility of side-effects for each individual. Recent clinical trials have show …
Precision medicine is a patient-specific approach that integrates all relevant clinical, genetic and biological information in order …
After asthma: redefining airways diseases.
Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, Cullinan P, Custovic A, Ducharme FM, Fahy JV, Frey U, Gibson P, Heaney LG, Holt PG, Humbert M, Lloyd CM, Marks G, Martinez FD, Sly PD, von Mutius E, Wenzel S, Zar HJ, Bush A. Pavord ID, et al. Among authors: agusti a. Lancet. 2018 Jan 27;391(10118):350-400. doi: 10.1016/S0140-6736(17)30879-6. Epub 2017 Sep 11. Lancet. 2018. PMID: 28911920 Free article. Review. No abstract available.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ, Bourbeau J, Celli BR, Chen R, Decramer M, Fabbri LM, Frith P, Halpin DM, López Varela MV, Nishimura M, Roche N, Rodriguez-Roisin R, Sin DD, Singh D, Stockley R, Vestbo J, Wedzicha JA, Agustí A. Vogelmeier CF, et al. Among authors: agusti a. Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582. doi: 10.1164/rccm.201701-0218PP. Am J Respir Crit Care Med. 2017. PMID: 28128970 Free article.
COPD 2020: changes and challenges.
Agustí A, Vogelmeier C, Faner R. Agustí A, et al. Am J Physiol Lung Cell Mol Physiol. 2020 Nov 1;319(5):L879-L883. doi: 10.1152/ajplung.00429.2020. Epub 2020 Sep 23. Am J Physiol Lung Cell Mol Physiol. 2020. PMID: 32964724 Free article. No abstract available.
From GOLD 0 to Pre-COPD.
Han MK, Agusti A, Celli BR, Criner GJ, Halpin DMG, Roche N, Papi A, Stockley RA, Wedzicha J, Vogelmeier CF. Han MK, et al. Among authors: agusti a. Am J Respir Crit Care Med. 2021 Feb 15;203(4):414-423. doi: 10.1164/rccm.202008-3328PP. Am J Respir Crit Care Med. 2021. PMID: 33211970 Free PMC article. No abstract available.
Lung function trajectories in health and disease.
Agusti A, Faner R. Agusti A, et al. Lancet Respir Med. 2019 Apr;7(4):358-364. doi: 10.1016/S2213-2600(18)30529-0. Epub 2019 Feb 11. Lancet Respir Med. 2019. PMID: 30765254 Review.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Vestbo J, et al. Among authors: agusti ag. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. doi: 10.1164/rccm.201204-0596PP. Epub 2012 Aug 9. Am J Respir Crit Care Med. 2013. PMID: 22878278 Review.
Today, GOLD recommends that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation. ...
Today, GOLD recommends that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper eval …
Inhaled corticosteroids in COPD: friend or foe?
Agusti A, Fabbri LM, Singh D, Vestbo J, Celli B, Franssen FME, Rabe KF, Papi A. Agusti A, et al. Eur Respir J. 2018 Dec 13;52(6):1801219. doi: 10.1183/13993003.01219-2018. Print 2018 Dec. Eur Respir J. 2018. PMID: 30190269 Free article. Review.
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of patients with chronic obstructive pulmonary disease (COPD) is much debated, since it can result in clear clinical benefits in some patients ("friend") but can be ineffective or even a …
The efficacy, safety and positioning of inhaled corticosteroids (ICS) in the treatment of patients with chronic obstructive pulmonary diseas …
410 results